3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow AKI: new trials by email Literature Review of AKI trials Research Report on AKI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery Low Dose RBT-1, High Dose RBT-1, Placebo - AKI | Phase 2 | Completed | Renibus Therapeutics, Inc. | 152 | 2021-08-04 | 2024-04-15 |
| Protection From Acute Kidney Injury (AKI) With Basis™ Treatment Nicotinamide Riboside + Pterostilbene, Placebo - AKI | Phase 2 | Completed | Mayo Clinic | 54 | 2020-12-01 | 2024-04-23 |
| Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury Dextran 40 - Cirrhosis, Liver, AKI | Phase 2 / Phase 3 | Completed | Ramathibodi Hospital | 10 | 2015-07-01 | 2017-03-03 |
Acute Kidney Injury (1) · Fibrosis (1) · Liver Cirrhosis (1)
Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Liver Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Dextrans (1) · Pterocarpus marsupium (1) · Radial Basis Function Networks (1) · nicotinamide-beta-riboside (1)
Mayo Clinic (1) · Ramathibodi Hospital (1) · Renibus Therapeutics, Inc. (1)
United States (2) · Australia (1) · Canada (1)
Abhasnee Sobhonslidsuk, MD (1) · Bernardo Mendes, MD (1)